The Company shall have in all material respects performed, and be in compliance with, all obligations, agreements, covenants, closing conditions and other provisions contained in the Amended and Restated Recapitalization Agreement by and between the...Northwest Biotherapeutics Inc • April 18th, 2006 • Pharmaceutical preparations
EXHIBIT 10.27 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR...Northwest Biotherapeutics Inc • April 18th, 2006 • Pharmaceutical preparations • Washington
SERIES D INVESTORS' RIGHTS AGREEMENTNorthwest Biotherapeutics Inc • October 10th, 2001 • Pharmaceutical preparations • Washington
EXHIBIT 1 JOINT FILING AGREEMENTNorthwest Biotherapeutics Inc • May 25th, 2004 • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that the Amendment No. 4 to Schedule 13G to which this Joint Filing Statement is being filed as an exhibit shall be a joint statement filed on behalf of each of the undersigned.
WARRANTNorthwest Biotherapeutics Inc • April 18th, 2006 • Pharmaceutical preparations • Delaware
FORM OF COMMON STOCK PURCHASE WARRANT CLASS D-3 NORTHWEST BIOTHERAPEUTICS, INC.Northwest Biotherapeutics Inc • June 28th, 2018 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______, 2020 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 22nd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 20, 2017, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 19th, 2016 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
This Agreement is made pursuant to the certain letter agreement, dated as of the date hereof, between the Company and each Purchaser (the “Letter Agreement”).
EXHIBIT 10.1 SETTLEMENT AGREEMENT This Settlement Agreement (this "Agreement") is made effective as of June 30, 2003, by and between NEXUS CANYON PARK LLC, a Delaware limited liability company ("Nexus" or "Landlord"), and NORTHWEST BIOTHERAPEUTICS,...Settlement Agreement • August 14th, 2003 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
UNDERWRITING AGREEMENT between NORTHWEST BIOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters NORTHWEST BIOTHERAPEUTICS, INC.Underwriting Agreement • December 4th, 2012 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
The undersigned, Northwest Biotherapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Northwest Biotherapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
WARRANTNorthwest Biotherapeutics Inc • June 21st, 2005 • Pharmaceutical preparations • Delaware
EXHIBIT 10.2 INDUSTRIAL LEASE - MULTIPLE TENANT THIS LEASE AGREEMENT made this 18th day of June, 2003, by and between Benaroya Capital Company, LLC, a Washington limited liability company (the "Lessor") and Northwest Biotherapeutics, Inc., a Delaware...Lease Agreement • August 14th, 2003 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
EXHIBIT 10.3 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR...Northwest Biotherapeutics Inc • November 14th, 2003 • Pharmaceutical preparations • Washington
RECITALS:Security Agreement • November 14th, 2003 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
WARRANTNorthwest Biotherapeutics Inc • August 6th, 2004 • Pharmaceutical preparations • Delaware
RECITALSSecurities Purchase Agreement • February 1st, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.4 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement"), dated as of April 19, 2001, and effective as of February 2, 2001 (the "Effective Date"), is made and entered into by and between Northwest Biotherapeutics, Inc., a...Employment Agreement • August 13th, 2001 • Northwest Biotherapeutics Inc • Textile mill products
COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Northwest Biotherapeutics Inc • August 7th, 2017 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business at 5:00 p.m. (New York City time) on _____1 (the “Termination Date) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.23 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA UNIVERSITY OF CALIFORNIA, LOS ANGELES AGREEMENT NO. 081082716 This Agreement is entered into this April 4, 2001, by and between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California...Northwest Biotherapeutics Inc • October 24th, 2001 • Pharmaceutical preparations
BETWEENSublease Agreement • October 10th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
EXECUTION VERSION EXHIBIT ESubordination Agreement • May 14th, 2004 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Common Stock Purchase Warrant • September 22nd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business at 5:00 p.m. (New York City time) on _____1 (the “Termination Date) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
RECITALSSecurities Purchase Agreement • March 31st, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 9th, 2013 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 8, 2013, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.2 FORM OF WARRANT THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR WITH ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD...Northwest Biotherapeutics Inc • March 31st, 2006 • Pharmaceutical preparations • New York
NORTHWEST BIOTHERAPEUTICS, INC., and The Bank of New York Mellon, as Trustee INDENTURE Dated as of August 19, 2014 5.00% Convertible Senior Notes due 2017Indenture • August 25th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of August 19, 2014, between Northwest Biotherapeutics, Inc., a Delaware corporation, as issuer (hereinafter sometimes called the “Company”, as more fully set forth in Section 1.01), and The Bank of New York Mellon, a national banking association, as trustee (hereinafter sometimes called the “Trustee”, as more fully set forth in Section 1.01).
WARRANTNorthwest Biotherapeutics Inc • December 30th, 2004 • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 22nd, 2013 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 17, 2013, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.2 CONVERTIBLE SECURED PROMISSORY NOTENorthwest Biotherapeutics Inc • November 14th, 2003 • Pharmaceutical preparations • Washington
LEASE AGREEMENT (CONTINUED)Lease Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
BACKGROUNDDevelopment Agreement • August 13th, 2001 • Northwest Biotherapeutics Inc • Textile mill products • Washington
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 14th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 9, 2014, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).
COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Northwest Biotherapeutics Inc • December 29th, 2015 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June __, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
UNDERWRITING AGREEMENT UNDERWRITING AGREEMENTUnderwriting Agreement • October 10th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
1 EXHIBIT 10.20 NORTHWEST BIOTHERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENTInvestors' Rights Agreement • October 10th, 2001 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
